Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Stefania Porto"'
Autor:
Paola Stiuso, Nicoletta Potenza, Angela Lombardi, Ida Ferrandino, Antonio Monaco, Silvia Zappavigna, Daniela Vanacore, Nicola Mosca, Filomena Castiello, Stefania Porto, Raffaele Addeo, Salvatore Del Prete, Ferdinando De Vita, Aniello Russo, Michele Caraglia
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 4, Iss C (2015)
Hepatocellular carcinoma (HCC) is the third cause of cancer-related deaths worldwide. Sorafenib is the only approved drug for patients with advanced HCC but has shown limited activity. microRNAs (miRs) have been involved in several neoplasms includin
Externí odkaz:
https://doaj.org/article/8e41873523264ad8b63c164b53361482
Autor:
Stephan V. Kozhukharov, Christian Girginov, Stefania Portolesi, Aleksandar Tsanev, Vanya Lilova, Mariya Georgieva, Emil Lilov, Plamen Petkov
Publikováno v:
Journal of Electrochemical Science and Engineering (2024)
Although their exceptional re-passivation ability, Al-alloys are susceptible to corrosion due to the amphoteric nature of the alumina passivation films. This issue is exacerbated by the disruption of these films by intermetallics on the surfaces of h
Externí odkaz:
https://doaj.org/article/02f72e2ca1be4abea9dd98611ed8acc6
Autor:
Silvia Zappavigna, Stefania Porto, Luigi Mele, Michele Caraglia, Vincenzo Desiderio, Monica Lamberti, Paola Stiuso, Virginia Tirino
Publikováno v:
International Journal of Oncology
5-Fluorouracil (5-FU), often used in combination with levofolene (LF), can induce, as an important side effect, the hand-foot syndrome (HFS) due to toxicity on keratinocytes. This can also damage workers involved in its handling. In the present study
Autor:
Ornella Gaito, Silvia Zappavigna, Mario De Rosa, Chiara Schiraldi, Sara Lusa, Stefania Porto, Antonella D Agostino, Michele Caraglia, Giuseppe De Rosa, Monica Lamberti
Publikováno v:
Cancer Biology & Therapy. 15:1524-1532
none 10 no Time-lapse live cell imaging is a powerful tool for studying the responses of cells to drugs. Zoledronic acid (ZOL) is the most potent aminobiphosphonate able to induce cell growth inhibition at very low concentrations. The lack of clear e
Autor:
Valerio Pazienza, Carlo Cervi, Stefania Porto, Concetta Panebianco, Oriana Lo Re, Manlio Vinciguerra, Francesca Rappa, Stefano Di Biase, Michele Caraglia
BACKGROUND: Hepatocellular carcinoma (HCC) has a poor outcome. Most HCCs develop in the context of liver fibrosis and cirrhosis caused by chronic inflammation. Short-term fasting approaches enhance the activity of chemotherapy in preclinical cancer m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::400dcc725dca95d20151efd8f9c18553
http://hdl.handle.net/11591/373336
http://hdl.handle.net/11591/373336
Autor:
Michele Caraglia, Paola Stiuso, Monica Marra, Erasmo Addeo, Silvia Zappavigna, N Sannolo, Monica Lamberti, Stefania Porto, Daniela Vanacore, Nadia Miraglia
Publikováno v:
Toxicology Letters. 227:151-156
Fluoropyrimidines are key agents for the treatment of gastrointestinal tract adenocarcinomas. The possible cardiotoxic effects in patients and occupationally exposed workers are multifactorial and remain a puzzle to solve for investigators. In the pr
Autor:
Monica Lamberti, Marina Di Domenico, Elpidio Maria Garzillo, Stefania Porto, Vincenzo Tombolini, Franca Avino, Giancarlo Giovane, Antonia Feola
Publikováno v:
BioMed Research International, Vol 2014 (2014)
BioMed Research International
BioMed Research International
Cardiotoxicity is an important side effect of cytotoxic drugs and may be a risk factor of long-term morbidity for both patients during therapy and also for staff exposed during the phases of manipulation of antiblastic drugs. The mechanism of cardiot
Autor:
Giuseppe De Rosa, Michele Caraglia, Chiara Riganti, Vincenzo Desiderio, Sara Lusa, Dario Antonio Ghigo, Elena Gazzano, Antonio Giordano, Martha L. Pinzon-Daza, Giuseppina Salzano, Joanna Kopecka, Stefania Porto
Publikováno v:
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
ResearcherID
Oncotarget
Universidad del Rosario
instacron:Universidad del Rosario
ResearcherID
Oncotarget
The resistance to chemotherapy and the tumor escape from host immunosurveillance are the main causes of the failure of anthracycline-based regimens in breast cancer, where an effective chemo-immunosensitizing strategy is lacking. The clinically used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9542c71f17fec3a250c253aafc30e0
http://hdl.handle.net/11365/997445
http://hdl.handle.net/11365/997445
Autor:
Stefania Porto, Gianpaolo Papaccio, Vincenzo Desiderio, Paola Stiuso, Stefania Galdiero, Emiliana Perillo, Annarita Falanga, Michele Caraglia, Virginia Tirino, Massimiliano Galdiero, Antonio Giordano, Silvia Zappavigna
Publikováno v:
Oncotarget
ResearcherID
ResearcherID
New delivery systems including liposomes have been developed to circumvent drug resistance. To enhance the antitumor efficacy of liposomes encapsulating anti-cancer agents, we used liposomes externally conjugated to the 20 residue peptide gH625. Phys
Autor:
Eleonora Da Pozzo, Stefania Vultaggio, Andrea Miele, Valeria Famiglini, Vitalba Ruggieri, Claudia Martini, Antonio Coluccia, Ettore Novellino, Sveva Pelliccia, Michele Caraglia, Ruoli Bai, Alberto Gulino, Chiara Bigogno, Biancamaria Ricci, Sara Passacantilli, Alessandra Soriani, Marianna Nalli, Luciana Marinelli, Ciro Mercurio, Giuseppe La Regina, Ludovica Monti, Angela Santoni, Giulio Dondio, Ernest Hamel, Andrea Brancale, Romina Alfonsi, Mario Varasi, Patrizia Lavia, Carmela Mazzoccoli, Lucia Di Marcotullio, Annalisa Verrico, Stefania Porto, Romano Silvestri
Publikováno v:
Journal of medicinal chemistry 58 (2015): 5789–5807. doi:10.1021/acs.jmedchem.5b00310
info:cnr-pdr/source/autori:La Regina, Giuseppe; Bai, Ruoli; Coluccia, Antonio; Farniglini, Valeria; Pelliccia, Sveva; Passacantilli, Sara; Mazzoccoli, Carmela; Ruggieri, Vitalba; Verrico, Annalisa; Miele, Andrea; Monti, Ludovica; Nalli, Marianna; Alfonsi, Romina; Di Marcotullio, Lucia; Gulino, Alberto; Ricci, Biancamaria; Soriani, Alessandra; Santoni, Angela; Caraglia, Michele; Porto, Stefania; Da Pozzo, Eleonora; Martini, Claudia; Brancale, Andrea; Marinelli, Luciana; Novellino, Ettore; Vultaggio, Stefania; Varasi, Mario; Mercurio, Ciro; Bigogno, Chiara; Dondio, Giulio; Hamel, Ernest; Lavia, Patrizia; Silvestri, Romano/titolo:New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer/doi:10.1021%2Facs.jmedchem.5b00310/rivista:Journal of medicinal chemistry/anno:2015/pagina_da:5789/pagina_a:5807/intervallo_pagine:5789–5807/volume:58
info:cnr-pdr/source/autori:La Regina, Giuseppe; Bai, Ruoli; Coluccia, Antonio; Farniglini, Valeria; Pelliccia, Sveva; Passacantilli, Sara; Mazzoccoli, Carmela; Ruggieri, Vitalba; Verrico, Annalisa; Miele, Andrea; Monti, Ludovica; Nalli, Marianna; Alfonsi, Romina; Di Marcotullio, Lucia; Gulino, Alberto; Ricci, Biancamaria; Soriani, Alessandra; Santoni, Angela; Caraglia, Michele; Porto, Stefania; Da Pozzo, Eleonora; Martini, Claudia; Brancale, Andrea; Marinelli, Luciana; Novellino, Ettore; Vultaggio, Stefania; Varasi, Mario; Mercurio, Ciro; Bigogno, Chiara; Dondio, Giulio; Hamel, Ernest; Lavia, Patrizia; Silvestri, Romano/titolo:New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer/doi:10.1021%2Facs.jmedchem.5b00310/rivista:Journal of medicinal chemistry/anno:2015/pagina_da:5789/pagina_a:5807/intervallo_pagine:5789–5807/volume:58
We designed 39 new 2-phenylindole derivatives as potential anticancer agents bearing the 3,4,5-trimethoxyphenyl moiety with a sulfur, ketone, or methylene bridging group at position 3 of the indole and with halogen or methoxy substituent(s) at positi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be2aed7bff1d53ca2e59418be3849ec1